Atkinson Edward Morrow III
Insider CIK 1914164 · ETNB Director · VRTX EVP, Chief Technical Ops. Off.
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2026-02-25 | 2026-02-26 | 668 | $486.35 | $324.9K | 18,432 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2026-02-24 | 2026-02-26 | 1,627 | $485.11 | $789.3K | 19,100 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2026-02-18 | 2026-02-19 | 817 | $473.68 | $387.0K | 20,727 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2026-02-17 | 2026-02-19 | 2,031 | $489.46 | $994.1K | 21,544 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2026-02-17 | 2026-02-19 | 1,530 | $483.75 | $740.1K | 23,575 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2026-02-17 | 2026-02-19 | 4,962 | — | $0 | 25,105 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2026-02-13 | 2026-02-18 | 1,903 | $487.76 | $928.2K | 20,143 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2026-02-11 | 2026-02-12 | 1,751 | $460.43 | $806.2K | 22,046 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2026-02-10 | 2026-02-12 | 872 | $468.41 | $408.5K | 23,797 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2026-01-22 | 2026-01-26 | 3,883 | — | $0 | 24,669 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2026-01-22 | 2026-01-26 | 3,934 | — | $0 | 20,786 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2025-11-17 | 2025-11-19 | 2,500 | $434.58 | $1.09M | 16,852 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-10-30 | 56,400 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-10-30 | 45,150 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-10-30 | 27,400 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-10-30 | 20,000 | — | $0 | 0 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2025-02-27 | 2025-02-28 | 2,650 | $475.34 | $1.26M | 19,352 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2025-02-26 | 2025-02-28 | 2,482 | $479.61 | $1.19M | 22,002 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2025-02-25 | 2025-02-26 | 1,767 | $480.95 | $849.8K | 24,484 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2025-02-24 | 2025-02-26 | 1,656 | $483.28 | $800.3K | 26,251 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2025-02-14 | 2025-02-19 | 1,529 | $463.46 | $708.6K | 27,907 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2025-02-12 | 2025-02-14 | 6,211 | — | $0 | 29,436 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2025-02-11 | 2025-02-12 | 1,747 | $459.83 | $803.3K | 23,225 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2025-02-10 | 2025-02-12 | 876 | $467.98 | $410.0K | 24,972 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2025-02-04 | 2025-02-06 | 4,744 | — | $0 | 25,848 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2025-02-04 | 2025-02-06 | 5,132 | — | $0 | 21,104 | SEC↗ |
| ETNB 89bio, Inc. | A Award deriv | 2025-02-03 | 2025-02-05 | 56,400 | — | $0 | 56,400 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2024-06-12 | 2024-06-13 | 7,288 | $478.00 | $3.48M | 15,972 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2024-06-11 | 2024-06-13 | 6,824 | $481.96 | $3.29M | 23,260 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2024-05-14 | 2024-05-16 | 14,112 | — | $0 | 30,084 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2024-02-26 | 2024-02-27 | 883 | $425.70 | $375.9K | 15,972 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2024-02-23 | 2024-02-27 | 1,654 | $431.79 | $714.2K | 16,855 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2024-02-21 | 2024-02-23 | 1,201 | $421.77 | $506.5K | 18,509 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2024-02-20 | 2024-02-21 | 801 | $420.79 | $337.1K | 19,710 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2024-02-20 | 2024-02-21 | 1,125 | $420.58 | $473.2K | 20,511 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2024-02-16 | 2024-02-21 | 1,501 | $424.01 | $636.4K | 21,636 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2024-02-12 | 2024-02-13 | 913 | $420.24 | $383.7K | 23,137 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | F Tax w/h | 2024-02-09 | 2024-02-13 | 832 | $422.74 | $351.7K | 24,050 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2024-02-07 | 2024-02-08 | 4,743 | — | $0 | 24,882 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2024-02-06 | 2024-02-08 | 3,934 | — | $0 | 20,139 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2024-02-06 | 2024-02-08 | 2,326 | — | $0 | 16,205 | SEC↗ |
| ETNB 89bio, Inc. | A Award deriv | 2024-02-01 | 2024-02-05 | 45,150 | — | $0 | 45,150 | SEC↗ |
| ETNB 89bio, Inc. | M Exercise deriv | 2023-06-01 | 2023-06-05 | 6,250 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | S Sale | 2023-06-01 | 2023-06-05 | 6,250 | $17.91 | $111.9K | 0 | SEC↗ |
| ETNB 89bio, Inc. | M Exercise | 2023-06-01 | 2023-06-05 | 6,250 | $2.61 | $16.3K | 6,250 | SEC↗ |
| ETNB 89bio, Inc. | M Exercise deriv | 2023-03-01 | 2023-03-03 | 10,000 | — | $0 | 20,000 | SEC↗ |
| ETNB 89bio, Inc. | S Sale | 2023-03-01 | 2023-03-03 | 10,000 | $13.60 | $136.0K | 0 | SEC↗ |
| ETNB 89bio, Inc. | M Exercise | 2023-03-01 | 2023-03-03 | 10,000 | $4.44 | $44.4K | 10,000 | SEC↗ |
| ETNB 89bio, Inc. | A Award deriv | 2023-02-09 | 2023-02-13 | 27,400 | — | $0 | 27,400 | SEC↗ |
| ETNB 89bio, Inc. | A Award deriv | 2022-05-25 | 2022-05-27 | 6,250 | — | $0 | 6,250 | SEC↗ |